Covered recipient · General Payments record
SUSANNAH MARRISA ALBA-PADRON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2024
$523.02
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $523.02 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $159.55 | 5 |
| Axsome Therapeutics, Inc. | $122.80 | 1 |
| Teva Pharmaceuticals USA, Inc. | $73.55 | 2 |
| Alkermes, Inc. | $68.20 | 4 |
| Lilly USA, LLC | $27.91 | 1 |
| Novo Nordisk AS | $25.00 | 1 |
| Gilead Sciences, Inc. | $23.08 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.93 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $523.02 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $105.26 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106421666 | CMS |
| ABBVIE INC. | $21.78 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106421668 | CMS |
| ABBVIE INC. | $3.27 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106421670 | CMS |
| ABBVIE INC. | $26.99 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106421672 | CMS |
| ABBVIE INC. | $2.25 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106421674 | CMS |
| Alkermes, Inc. | $13.75 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120455664 | CMS |
| Alkermes, Inc. | $20.93 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120455666 | CMS |
| Alkermes, Inc. | $18.00 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120455668 | CMS |
| Alkermes, Inc. | $15.52 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120455670 | CMS |
| Axsome Therapeutics, Inc. | $122.80 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148413156 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.93 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118051817 | CMS |
| Gilead Sciences, Inc. | $23.08 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133702440 | CMS |
| Lilly USA, LLC | $27.91 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949780 | CMS |
| Novo Nordisk Inc | $25.00 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588099 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.37 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151589547 | CMS |
| Teva Pharmaceuticals USA, Inc. | $51.18 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151589605 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.